In 2026, AI research is moving beyond raw scaling to focus on efficiency, adaptability, and operational robustness. Advances in architectures, benchmarks, and conferences reflect a growing emphasis on ...
Hosted on MSN
2026 Metabolomics Shift: LIPID MAPS, Agilent, and Thermo Fisher Redefine Lipid Workflows
As of May 2026, the metabolomics community is witnessing a convergence of open-source database innovation and proprietary software intelligence. LIPID MAPS recently published a landmark focus article ...
(Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced the appointment of Anthony Bazarko as Chief Commercial Officer. Mr. Bazarko brings more than two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results